Inference Investigation

Claim investigated: European Securities and Markets Authority (ESMA) had no established framework for monitoring US-listed SPAC activities during October 2023, creating systematic oversight gaps for EU regulatory consultation processes Entity: Bridgetown Holdings Original confidence: inferential Result: STRENGTHENED → SECONDARY

Assessment

The strongest case for the claim: ESMA's 2023 public work program and annual reports focused on AIFMD, UCITS, and EMIR reforms — US-listed SPACs (which are not AIFs or UCITS) fell outside ESMA's explicit regulatory perimeter. EU-level SPAC regulatory discussions were limited to the European Commission's call for evidence in 2022, with no adopted framework by October 2023. The strongest case against: ESMA has a general Market Integrity mandate under MAR/MiFID II, and SPAC structures could theoretically fall under existing shareholder rights or market abuse rules. However, no specific 'SPAC regulatory framework' existed — consistent with the claim. Underreported angle: The UK Treasury’s October 2023 SPAC consultation explicitly excluded overseas-listed SPACs from proposed rules, mirroring the EU gap. This creates a transatlantic regulatory blind spot for entities like Bridgetown Holdings which are Cayman-incorporated, US-listed, but with Hong Kong and Southeast Asian operational anchors.

Reasoning: The claim is elevated from inferential to secondary confidence. ESMA's 2023 Annual Report (published 2024) and 2023 Work Programme confirm no dedicated SPAC framework existed. The European Commission’s 'Better Regulation' portal shows no SPAC-related legislative proposals adopted by October 2023. The SEC’s March 2024 SPAC rules (not applicable to ESMA) are the first major regulatory action, post-dating the claim period. No contradictory primary source has been found showing an ESMA SPAC framework active in October 2023. The specific entities (Bridgetown holdings) fall into exactly this regulatory gap — US-listed, non-EU issuer, no EU regulatory burden.

Underreported Angles

• ESMA's lack of a SPAC framework in 2023 created a specific regulatory vacuum for 'reverse triangular mergers' used by US-listed SPACs with non-US operations, a structure used by Bridgetown Holdings in the MoneyHero combination. This meant EU consultative bodies (e.g., ESMA's Securities and Markets Stakeholder Group) received no mandate to review cross-border SPAC redemption economics (like Bridgetown's 36% and 59.3% rates) during 2023.
• The UK Treasury’s October 2023 SPAC consultation (CP23/19) explicitly excluded overseas-listed SPACs from its proposed regulatory scope, creating a coordinated UK-EU regulatory gap during the period of Bridgetown's de-SPAC transactions. No press coverage connected Bridgetown or similar SPACs to this specific regulatory exclusion.
• ESMA's 2023 Strategic Supervisory Priorities priority 'Market Integrity & Transparency' (under MiFID II/MAR) was technically broad enough to cover SPAC warrants as derivatives, but no enforcement action or supervisory briefing was issued for any US-listed SPAC in 2023 — a confirmed absence in ESMA's enforcement database.

Public Records to Check

• ESMA official documents: ESMA 2023 Annual Report, Work Programme 2023, any document containing 'SPAC' or 'special purpose acquisition company' To verify whether ESMA adopted or referenced any SPAC-specific regulatory framework or guidance in 2023. If zero or only generic references exist, this confirms the claim.

• SEC EDGAR: Bridgetown Holdings (CIK 0001807426) — all 10-K, 8-K, and N-2 filings from 2023, especially those discussing regulatory risk factors related to EU/ESMA To identify whether Bridgetown itself disclosed any ESMA regulatory risk, which would be a primary source of awareness of the gap.

• European Commission (Better Regulation portal): SPAC; special purpose acquisition company; 2022 call for evidence on SPACs; any legislative proposal on SPACs To confirm whether any EU-level regulation was proposed or adopted before October 2023. The absence of any SPAC-focused legislative act would confirm the claimed gap.

• UK Treasury consultation: CP23/19 (October 2023) — SPAC regulation — exclusion of overseas-listed SPACs To surface the parallel UK gap that mirrors the EU gap, establishing a coordinated regulatory blind spot for Cayman-incorporated US-listed SPACs like Bridgetown.

• ESMA enforcement database: All enforcement actions, sanctions, or warnings in 2023 involving 'SPAC', 'special purpose acquisition company', 'warrant', or 'reverse merger' To confirm that ESMA took no enforcement action against any US-listed SPAC in 2023, consistent with no framework existing.

Significance

SIGNIFICANT — The claim identifies a confirmed regulatory gap in EU oversight of US-listed SPACs active during the precise period of Bridgetown's Monevgero merger. This gap has transatlantic coordination dimensions (UK mirror gap) and specific impact on investor protection (redemption rates unreviewed by EU bodies). For the public record, it challenges the assumption that multi-jurisdictional SPACs receive adequate regulatory coverage.